Loading…
Loading…
are you finding that that's actually translating the spending plans
Is mid singles plus the right way to think about things
I'm just curious whether demand from small and emerging biotech is getting any better from where you sit
what are you seeing on the research and industrial side? Is that fluid in a way that you think introduces some additional risk
can you just maybe expand on the extent to which it feels like the spending decisions are being influenced by the macro factors at play
just given the moving parts on the hardware side, it would be helpful to know how you see growth there in the back half